Bolt Biotherapeutics, Inc.
BOLT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $18 | $10 | $8 | $7 |
| Short-Term Investments | $14 | $25 | $30 | $40 |
| Receivables | $0 | $0 | $1 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $4 | $3 | $2 |
| Total Curr. Assets | $36 | $38 | $43 | $51 |
| Property Plant & Equip (Net) | $21 | $22 | $23 | $25 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $7 | $14 | $19 | $23 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $1 | $1 |
| Total NC Assets | $29 | $37 | $43 | $49 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $65 | $75 | $86 | $100 |
| Liabilities | – | – | – | – |
| Payables | $2 | $2 | $2 | $2 |
| Short-Term Debt | $3 | $3 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $2 | $3 | $3 | $3 |
| Other Curr. Liab. | $4 | $5 | $7 | $9 |
| Total Curr. Liab. | $10 | $12 | $14 | $16 |
| LT Debt | $21 | $22 | $22 | $23 |
| Deferred Rev, NC | $0 | $3 | $3 | $4 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $0 | $0 | $0 |
| Total NC Liab. | $23 | $24 | $25 | $27 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $24 | $25 | $25 |
| Total Liabilities | $33 | $37 | $39 | $42 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$454 | -$447 | -$438 | -$427 |
| AOCI | -$0 | -$0 | $0 | $0 |
| Other Equity | $486 | $486 | $485 | $485 |
| Total Equity | $32 | $39 | $47 | $57 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $65 | $75 | $86 | $100 |
| Net Debt | $6 | $15 | $16 | $18 |